Follow
Jonathan A Chen
Jonathan A Chen
Verified email at nih.gov
Title
Cited by
Cited by
Year
Federated learning enables big data for rare cancer boundary detection
S Pati, U Baid, B Edwards, M Sheller, SH Wang, GA Reina, P Foley, ...
Nature communications 13 (1), 7346, 2022
1502022
Sexually dimorphic radiogenomic models identify distinct imaging and biological pathways that are prognostic of overall survival in glioblastoma
N Beig, S Singh, K Bera, P Prasanna, G Singh, J Chen, ...
Neuro-oncology 23 (2), 251-263, 2021
322021
NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts
D Zhang, HM Harris, J Chen, J Judy, G James, A Kelly, J McIntosh, ...
Blood 141 (13), 1584-1596, 2023
162023
CD49d expression identifies a biologically distinct subtype of chronic lymphocytic leukemia with inferior progression-free survival on BTK inhibitor therapy
A Alsadhan, J Chen, EM Gaglione, C Underbayev, PL Tuma, X Tian, ...
Clinical Cancer Research 29 (18), 3612-3621, 2023
102023
Humoral and cellular immunogenicity of COVID-19 vaccinations in patients with CLL
C Sun, EM Gaglione, LT Vaughn, R Mu, C Underbayev, J Chen, C Pleyer, ...
Blood 138, 3724, 2021
52021
Novel MRI deformation-heterogeneity radiomic features are associated with molecular subgroups and overall survival in pediatric medulloblastoma: Preliminary findings from a …
S Iyer, M Ismail, B Tamrazi, R Salloum, P de Blank, A Margol, R Correa, ...
Frontiers in Oncology 12, 915143, 2022
32022
" Lesion-habitat" radiomics to distinguish radiation necrosis from tumor recurrence on post-treatment MRI in metastatic brain tumors
R Correa, Q Lei, J Chen, J Zeng, J Yu, P Tiwari
Medical Imaging 2020: Computer-Aided Diagnosis 11314, 704-709, 2020
32020
CLL-140 booster and BTKi interruption improve response to SARS-CoV-2 vaccine in patients with CLL
E Bryer, S Paul, J Chen, C Pleyer, A Wiestner, C Sun
Clinical Lymphoma Myeloma and Leukemia 22, S270-S271, 2022
22022
Sex-specific niche signaling contributes to sexual dimorphism following stem cell transplantation
JNP Smith, BA Cordova, B Richardson, KF Christo, J Campanelli, ...
bioRxiv, 2022.06. 13.495897, 2022
12022
NEIM-01. PREDICTION OF RESPONSE TO COMBINATION OF NIVOLUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA VIA RADIOMIC ANALYSIS ON CLINICAL MRI SCANS
R Verma, Y Rauf, I Yadav, V Statsevych, J Chen, W Evanoff, M Ahluwalia, ...
Neuro-Oncology Advances 3 (Supplement_4), iv6-iv6, 2021
12021
Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL
E Bryer, S Paul, J Chen, C Pleyer, A Wiestner, C Sun
Clinical Lymphoma, Myeloma & Leukemia 22, S142, 2022
2022
3072–SEX-SPECIFIC NICHE SIGNALING CONTRIBUTES TO SEXUAL DIMORPHISM FOLLOWING STEM CELL TRANSPLANTATION
A Desai, J Smith, B Cordova, B Richardson, K Christo, J Campanelli, ...
Experimental Hematology 111, S80-S81, 2022
2022
RADIOMIC FEATURES FROM LESION HABITAT PREDICT RESPONSE TO COMBINATION OF NIVOLUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: A FEASIBILITY STUDY
R Verma, Y Rauf, I Yadav, V Statsevych, J Chen, W Evanoff, M Ahluwalia, ...
NEURO-ONCOLOGY 23, 141-141, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–13